Cohort study on HIV prevention in France
HIV Prevention in France : "Dat'AIDS Prevention"
This study looks at how well different HIV prevention methods work in France by gathering information from people getting tested and treated for HIV and related infections.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 6500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | DatAids Academic / other |
| Locations | 31 sites (Belfort and 30 other locations) |
| Trial ID | NCT03795376 on ClinicalTrials.gov |
What this trial studies
Dat'Aids Prevention is a cohort study that investigates various aspects of HIV prevention across over 23 sites in France, including overseas locations. The study focuses on HIV screening, STI and hepatitis screening, as well as post-exposure and pre-exposure prophylaxis. By gathering data from individuals attending these services, the study aims to provide a comprehensive overview of current HIV prevention strategies and their effectiveness. Participants will be monitored to assess the impact of these interventions on HIV prevention.
Who should consider this trial
Good fit: Ideal candidates for this study are HIV-negative individuals over 18 years old who are seeking HIV, STI, or hepatitis screening or treatment.
Not a fit: Patients who are already HIV-positive or refuse to participate will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of effective HIV prevention strategies, leading to improved health outcomes for at-risk populations.
How similar studies have performed: Other studies focusing on HIV prevention strategies have shown success, indicating that this approach is supported by prior research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male and female over 18 years old, * HIV negative * Attending for : * HIV screening * Hepatitis screening * STI screening / treatment * Blood, body fluid or sexual exposure * Post-exposure prophylaxis * Pre-exposure prophylaxis * Signed consent Exclusion Criteria: * HIV-infection * Refusal to participate
Where this trial is running
Belfort and 30 other locations
- Hôpital Nord Franche Comté — Belfort, France (Recruiting)
- CHU Besançon - Hôpital Jean Minjoz — Besançon, France (Recruiting)
- CHRU Brest — Brest, France (Recruiting)
- CHU Clermont-Ferrand - Hôpital Gabriel-Montpied — Clermont-Ferrand, France (Recruiting)
- CHD Vendée — La Roche-sur-Yon, France (Recruiting)
- Hôpital Bicêtre - Assistance Publique des Hôpitaux de Paris — Le Kremlin-Bicêtre, France (Recruiting)
- CHU Limoges — Limoges, France (Recruiting)
- Hôpital de la Croix-Rousse - Hospices Civils de Lyon — Lyon, France (Recruiting)
- Hôpital Sainte Marguerite - Assistance Publique des Hôpitaux de Marseille — Marseille, France (Recruiting)
- IHU - Assistance Publique des Hôpitaux de Marseille — Marseille, France (Recruiting)
- CHR Metz-Thionville — Metz, France (Recruiting)
- Hôpital Gui de Chauliac — Montpellier, France (Recruiting)
- CHU Nancy - Hôpital Brabois — Nancy, France (Recruiting)
- CHU Nantes - Hôtel-Dieu — Nantes, France (Recruiting)
- CHU Nice - Hôpital l'Archet — Nice, France (Recruiting)
- CH Nîmes — Nîmes, France (Recruiting)
- CHR Orléans — Orléans, France (Recruiting)
- Groupe Hospitalier Pitié Salpêtrière - Assistance Publique des Hôpitaux de Paris — Paris, France (Recruiting)
- Hôpital Bichat - Assistance Publique des Hôpitaux de Paris — Paris, France (Recruiting)
- Hôpital Necker-Pasteur - Assistance Publique des Hôpitaux de Paris — Paris, France (Recruiting)
- Centre Hospitalier de Cornouaille — Quimper, France (Recruiting)
- CHU Reims - Hôpital Robert Debré — Reims, France (Recruiting)
- CHU Rennes - Hôpital Pontchaillou — Rennes, France (Recruiting)
- CHU Rouen — Rouen, France (Recruiting)
- CHU St Etienne - Hôpital Nord — Saint-Etienne, France (Recruiting)
- CHU Strasbourg - Hôpital Civil — Strasbourg, France (Recruiting)
- CHU Toulouse - Hôpital Purpan — Toulouse, France (Recruiting)
- CHU Tourcoing - Hôpital Guy Chatiliez — Tourcoing, France (Recruiting)
- CH Bretagne-Atlantique — Vannes, France (Recruiting)
- CHU de Guadeloupe — Pointe-à-Pitre, Guadeloupe (Recruiting)
- CHU de Martinique — Fort-de-France, Martinique (Recruiting)
Study contacts
- Principal investigator: Pascal PUGLIESE, MD — Centre Hospitalier Universitaire de Nice
- Study coordinator: Pascal Pugliese, MD
- Email: pugliese.p@chu-nice.fr
- Phone: 0033492035802
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.